–
Статьи в журналах
-
- 2026 Trastuzumab deruxtecan (T-DXd) in pretreated patients (pts) with HER2-expressing bladder cancer: Final results from the bladder cancer cohort in Part 1 of DESTINY-PanTumor02 (DP-02)
- Jung Kyung Hae, Oh Do-Youn, Doroshow Deborah Blythe, Artamonova Elena, Mammatas Lemonitsa, Wysocki Piotr Jan, Su Po-Jung, Moiseyenko Vladimir, Penkov Konstantin, Stroyakovskiy Daniil, Bartolome Jorge, Siena Salvatore, Anoka Chiedozie, Scott Megan, Michelini Flavia, Puvvada Soham D., Makker Vicky
- в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 44, № 7_suppl, с. 734-734 DOI